 the term CLI, efforts to measure and compare
outcomes of different treatment options have been problematic, especially as revascularization options and other
treatment approaches have rapidly expanded.
For a disease staging system to be clinically relevant, it
must achieve two primary goals: (1) accurately provide risk
stratiﬁcation of patients with respect to disease natural
history, and (2) accurately stratify patients with sufﬁcient
granularity to allow meaningful comparison of different

JOURNAL